Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide in Relapsed/Refractory DLBCL and Hodgkin's Disease
NCT00209014Phase 2Terminated
- Sponsor
- Emory University
- Start
- Jul 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in diffuse large B-cell lymphoma (DLBCL), Hodgkin lymphoma (HL), sponsored by Emory University. Started Jul 2003; status: terminated.
02
Drugs
thalidomide
03
Conditions
diffuse large B-cell lymphoma (DLBCL)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00209014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00209014.